Contract Pharmaceutical Manufacturing Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Contract Pharmaceutical Manufacturing Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Report Description
Pharmaceutical companies are now pushing hard to reduce overall manufacturing and research costs by outsourcing various processes related to research, development and manufacturing. Furthermore, patent expiration and generic drug competition, continue to fuel demand for pharmaceutical contract manufacturing organizations in the market.
Rising number of Food and Drug Administration (FDA) approvals and clinical trials are supporting growth of biopharmaceutical industry, which in turn is fueling growth of the contract pharmaceutical manufacturing market. For instance, according to ClinicalTrials.gov, from September 2008 to October 2018, there were around 288,064 clinical trial studies registered. In addition, there is a significant increase over the past few years with registered clinical studies of 205,428, 233,234, and 262,429 in 2015, 2016, and 2021, respectively.
Furthermore, stringent regulatory policies for clinical research studies and manufacturing make entire drug manufacturing process more complex, as it requires more resources to develop new drugs and biologics. These processes require expertise in broad scientific disciplines of preclinical, clinical, ancillary clinical in chemistry, packaging, manufacturing, project management, and regulatory affairs, which are provided by the CROs and CMOs. This is considered as a major reason for pharmaceutical companies to outsource clinical trials and manufacturing processes.
Market Dynamics
Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to the complexity involved in manufacturing process of biomolecules, as it consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Furthermore, by outsourcing manufacturing capabilities from contract manufacturing organization, allows recruiter firms to focus more on the research and development (R&D), product development, and marketing aspects.
Pharmaceutical market is increasingly concentered with generic products and is highly competitive with various companies located in Asia Pacific, which are entering into the developed markets such as the U.S., Germany, France, and the U.K. Rising number of patents expiring in the near future serves to be a major opportunity for generic drugs manufacturers to prosper in the market.
Furthermore, mergers and acquisitions between generic drug manufacturers, with major players focusing on enhancing their product portfolio through inorganic strategies, will support the addition of generic drug portfolio into company’s offering and thus, generating demand for CMOs to fulfil it.
For instance, in August 2016, Teva Pharmaceuticals Industries strengthened its position in the generic drugs market through acquisition of the generic segment of Allergan, plc for US$ 40.5 billion. This resulted in significant growth in revenue contribution of its generic drug segment, pegged at US$ 9.5 billion in 2016.
Key features of the study:
This report provides in-depth analysis of contract pharmaceutical manufacturing market, its market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year.
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global contract pharmaceutical manufacturing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies.
Key companies covered as a part of this study includes Accenture plc, Cognizant Technology Solutions, ATOS SE, Catalent, Inc., Covance, Inc., Boehringer Ingelheim GmbH, Genpact Limited, Lonza Group, PAREXEL International Corporation, Quintiles Transnational Corporation, Abbvie, Inc., Baxter International Inc., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma, Pfizer, Inc., The Almac Group, Teva Pharmaceutical Industries Ltd. and Piramal Enterprises Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type upgradation, market expansion, and marketing tactics.
The global contract pharmaceutical manufacturing market report caters to various stakeholders in this industry including investors, researchers, contract pharmaceutical manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the contract pharmaceutical manufacturing market.
Detailed Segmentation:
Global contract pharmaceutical manufacturing market, By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
Global Contract Pharmaceutical Manufacturing Market, By Molecule Type:
Small Molecules
Large Molecules
Global Contract Pharmaceutical Manufacturing Market, By Geography:
North America
By Country:
U.S.
Canada
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Asia Pacific
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Africa
By Country:
North Africa
Central Africa
South Africa
By Service Type:
Contract Manufacturing Organization (CMO)
API Manufacturing
Final dosage form manufacturing
Packaging
Contract Research Organization (CRO)
Drug Discovery
Preclinical studies
Early Phase I - IIa
Phase IIa - III
Phase IIIb - IV
Medical coding and writing
Monitoring
Clinical Data Management
Bio-statistics
Site management
Protocol development
By Molecule Type:
Small Molecules
Large Molecules
Company Profiles
Accenture plc*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Cognizant Technology Solutions
ATOS SE
Catalent, Inc.
Covance, Inc.
Boehringer Ingelheim GmbH
Genpact Limited
Lonza Group
PAREXEL International Corporation
Quintiles Transnational Corporation
Abbvie, Inc.
Baxter International Inc.
Dr. Reddy’s Laboratories Ltd.
Aurobindo Pharma
Pfizer, Inc.
The Almac Group
Teva Pharmaceutical Industries Ltd.
Piramal Enterprises Ltd.
“*” marked represents similar segmentation in other categories in the respective section.